Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1) - Image 1

£82.66

Springer Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Name: Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)
Brand: Springer
Price: 82.66 GBP
Availability: InStock

Pharmacy - Dispensing

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£83 today · all-time low £79 (Apr 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 414 days • 414 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 414 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £79 (392 days, 94.7%)

Price range: £79 - £100

Price levels: 3 different prices over 414 days

Description

This book reports, for the first time, results from behavioral, neurochemical and molecular experiments which demonstrate a range of TIQs and BCs effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties. From the Back Cover This book summarizes, for the first time, the results from behavioral, neurochemical and molecular experiments, which demonstrate a wide spectrum of tetrahydroisoquinolines (TIQs) and beta-carbolines (BCs) effects - from their rather mild neurotoxic actions to the important neuroprotective and antiaddictive properties. Additionally, the recent results of experimental studies in vivo have allowed a much better understanding and simultaneous comparison of the neurochemical and molecular mechanisms underlying the neuroprotective and neurotoxic actions of endogenous TIQs and BCs and have pointed to the possibility of their therapeutic applications in neurodegenerative diseases such as Parkinson's disease. The specific topic, Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants – New Perspectives In Parkinson's Disease Therapy, was chosen in light of accumulating neurobiological evidence indicating that, in addition to exogenous neurotoxins (e.g., 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MPTP]), endogenous compounds may play an important role in the most common neurodegenerative disorders (e.g., Parkinson's disease). Two groups of amine related compounds, which appeared chemically like MPTP, were detected in human brain and cerebrospinal fluid (CSF): BCs and TIQs. These are heterocyclic compounds formed endogenously from phenylalanine/tyrosine (TIQs) and tryptophan, tryptamine, and 5-hydroxytryptamine (BCs), respectively, and exert a wide spectrum of psychopharmacological and behavioral effects. The TIQs and BCs may bind to their own high affinity sites on neuronal membranes associated with or located close to the receptors of neurotransmitters. Research on TIQs and BCs is stimulated also by their possible role in pathological conditions, especially parkinsonism and alcoholism. Recently, clinical interest has been spurred by their role as neuroprotective, and even neurorestorative, anticonvulsant and antiaddictive, substances.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1489987541
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 03 March 2014
Listed Since: 27 March 2014

Barcode

No barcode data available

Springer Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

About as cheap as it gets. The only time it was cheaper was 1 year ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Neurobiology of DOPA as a Neurotransmitter

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Serotonin: From Cell Biology to Pharmacology and Therapeutics

Neuropsychopharmacology: A Tribute to Joseph T. Coyle (Advances in Pharmacology): Volume 76

Advances in Neuropharmacology: Drugs and Therapeutics

Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Neuropsychopharmacology: 64 (Journal of Neural Transmission. Supplementa, 64)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Receptor Tyrosine Kinases: Family and Subfamilies

Tyrosine and Aspartic Acid: Properties, Sources and Health Benefits (Protein Biochemistry, Synthesis, Structure, and Cellular Functions)

Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)

Humana Tryptophan Metabolism - Health and Disease Book